"Melbourne, Australia; April 4 and New York, USA; April 3, 2025: Mesoblast (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s announcement on tariffs for imported products. Mesoblast believes that its allogeneic cellular products, including Ryoncil® and Revascor®, will not be subject to the tariffs."
Mesoblast believes....you wouldn't know what to believe with Trump would you????
Ann: Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.060(2.33%) |
Mkt cap ! $3.225B | |||
| Open | High | Low | Value | Volume |
| $2.58 | $2.61 | $2.50 | $12.63M | 4.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8366 | $2.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 8780 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |